Gender differences in substance-abuse treatment clients with co-occurring psychiatric and substance-use disorders

Brief Treatment and Crisis Intervention

Volumn 6, Issue 3, 2006, Pages 255-267

  Mangrum, Laurel F ^a   Spence, Richard T ^a   Steinley Bumgarner, Michelle D ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Co occurring disorders; Gender differences; Substance abuse treatment

Indexed keywords

EID: 33748068127     PISSN: 14743310     EISSN: 14743329     Source Type: Journal    
DOI: 10.1093/brief-treatment/mhl006     Document Type: Article

References (26)

1. Brunette, M. F., & Drake, R. E. (1997). Gender differences in patients with schizophrenia and substance abuse. Comprehensive Psychiatry, 38, 109-116.
2. Brunette, M. F., & Drake, R. E. (1998). Gender differences in homeless persons with schizophrenia and substance abuse. Community Mental Health Journal, 34, 627-642.
3. Compton, W. M., Cottler, L. B., Abdallah, A. B., Phelps, D. L., Spitznagel, E. L., & Horton, J. C. (2000). Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. The American Journal on Addictions, 9, 113-125.
4. Comtois, K. A., & Ries, R. K. (1995). Sex differences in dually diagnosed severely mentally ill clients in dual diagnosis outpatient treatment. The American Journal on Addictions, 4, 245-253.
5. Derogatis, L. R. (1978). Brief Derogatis Psychiatric Rating Scale. Minneapolis, MN: NCS Pearson.
6. Derogatis, L. R. (1993). Brief symptom inventory. Minneapolis, MN: NCS Pearson.
7. DiNitto, D. M., Webb, D. K., & Rubin, A. (2002). Gender differences in dually-diagnosed clients receiving chemical dependency treatment. Journal of Psychoactive Drugs, 34, 105-117.
8. Drake, R. E., Bartels, S. J., Teague, G. B., Noordsy, D. L., & Clark, R. E. (1993). Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease, 181, 606-611.
9. Drake, R. E., Mercer-McFadden, C., Muser, K. T., McHugo, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589-608.
10. Gearon, J. S., Nidecker, M. A., Bellack, A., & Bennett, M. (2003). Gender differences in drug use behavior in people with serious mental illness. The American Journal on Addictions, 12, 229-241.
11. Grella, C. E. (2003, May). Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatment. Journal of Psychoactive Drugs, (SARC Suppl. 1), 169-179.
12. Havassy, B. E., Alvidrez, J., & Owen, K. K. (2004). Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery. American Journal of Psychiatry, 161, 139-145.
13. Hien, D., Zimberg, S., Weisman, S., First, M., & Ackerman, S. (1997). Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatric Services, 48, 1058-1063.
14. Jerrell, J. M., & Ridgely, S. (1995). Gender differences in assessment of specialized treatments for substance abuse among people with severe mental illness. Journal of Psychoactive Drugs, 27, 347-355.
15. Kessler, R. C., Chui, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey. Archives of General Psychiatry, 62, 617-627.
16. Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Archives of General Psychiatry, 54, 313-321.
17. Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., et al. (1997). The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry, 12, 224-231.
18. Mangrum, L. F., & Spence, R. (2005, October). Treatment of co-occurring psychiatric and substance use disorders in mental health versus substance abuse service systems. Poster session presented at the annual Addiction Health Services Research Conference, Santa Monica, CA.
19. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grisson, G., et al. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9, 199-123.
20. Muser, K. T., Noordsy, D. L., Drake, R. E., & Fox, L. (2003). Research on integrated dual disorder treatment. In D. H. Barlow (Ed.), Integrated treatment for dual disorders: A guide to effective practice (pp. 301-305). New York: Guilford Press.
21. National Association of State Mental Health Program Directors & National Association of State Alcohol and Drug Abuse Directors. (1999). National dialogue on co-occurring mental health and substance use disorders. Washington, DC: National Association of State Alcohol and Drug Abuse Directors.
22. Primm, A. B., Gomez, M. B., Tzolova-Iontchev, I., Perry, W., Vu, H. T., & Crum, R. M. (2000). Mental health versus substance abuse treatment programs for dually diagnosed patients. Journal of Substance Abuse Treatment, 19, 285-290.
23. Regier, D. A., Narrow, W. E., Rae, D. S., Manderscheid, R. W., Locke, B. Z., & Goodwin, F. K. (1993). The de facto U.S. mental and addictive disorders service system: Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry, 50, 85-94.
24. Robins, L. N., & Regier, D. A. (Eds.). (1991). Psychiatric disorders in America: The epidemiologic catchment areas study. New York: The Free Press.
25. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Janavs, J., Weiller, E., Keskiner, A., et al. (1997). The validity of the mini international neuropyschiatric interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12, 232-241.
26. Sheehan, D. V., Lecrubier, Y. L., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl. 20), 22-33.